These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 29099488)
1. Mutant p53 partners in crime. Kim MP; Lozano G Cell Death Differ; 2018 Jan; 25(1):161-168. PubMed ID: 29099488 [TBL] [Abstract][Full Text] [Related]
2. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance. Stiewe T; Haran TE Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816 [TBL] [Abstract][Full Text] [Related]
3. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868 [TBL] [Abstract][Full Text] [Related]
4. Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism. Eriksson M; Ambroise G; Ouchida AT; Lima Queiroz A; Smith D; Gimenez-Cassina A; Iwanicki MP; Muller PA; Norberg E; Vakifahmetoglu-Norberg H Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993478 [No Abstract] [Full Text] [Related]
5. Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis. Stein Y; Rotter V; Aloni-Grinstein R Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817996 [TBL] [Abstract][Full Text] [Related]
6. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer. Hall C; Muller PAJ Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional activities of mutant p53: when mutations are more than a loss. Kim E; Deppert W J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312 [TBL] [Abstract][Full Text] [Related]
15. [Advances on mutant p53 research]. Li DH; Zhang LQ; He FC Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490 [TBL] [Abstract][Full Text] [Related]
16. p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo. Alexandrova EM; Mirza SA; Xu S; Schulz-Heddergott R; Marchenko ND; Moll UM Cell Death Dis; 2017 Mar; 8(3):e2661. PubMed ID: 28277540 [TBL] [Abstract][Full Text] [Related]
17. Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells. Cordani M; Butera G; Pacchiana R; Masetto F; Mullappilly N; Riganti C; Donadelli M Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111081 [TBL] [Abstract][Full Text] [Related]
18. Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression. Yue X; Zhang C; Zhao Y; Liu J; Lin AW; Tan VM; Drake JM; Liu L; Boateng MN; Li J; Feng Z; Hu W Genes Dev; 2017 Aug; 31(16):1641-1654. PubMed ID: 28947497 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation. Shetzer Y; Molchadsky A; Rotter V Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27235476 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. Pfister NT; Prives C Cold Spring Harb Perspect Med; 2017 Feb; 7(2):. PubMed ID: 27836911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]